Among the 10 ALT osteosarcoma cell lines, 5 harbored ATRX alterations and no TOP3A amplification, 2 harbored no ATRX alteration and TOP3A amplification, and 3 neither of the 2; statistical analysis, however, gave a non-significant result (p = 0.44). This evidence concerns the gene TOP3A and osteosarcoma.